메뉴 건너뛰기




Volumn 67, Issue 1, 2009, Pages

Extreme anemia in an injured Jehovah's witness: A test of our understanding of the physiology of severe anemia and the threshold for blood transfusion

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; BENZODIAZEPINE DERIVATIVE; FRESH FROZEN PLASMA; IRON; RECOMBINANT ERYTHROPOIETIN; VITAMIN K GROUP; HEMOGLOBIN; HEMOSTATIC AGENT;

EID: 70350447422     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e318047bfc8     Document Type: Article
Times cited : (12)

References (12)
  • 2
  • 3
  • 5
    • 0028834344 scopus 로고
    • Traumatically injured Jehovah's Witnesses: A sixteen-year experience of treatment and transfusion dilemmas at a level I trauma center
    • Nelson BS, Heiskell LE, Cemaj S, O'Callaghan TA, Koller CE. Traumatically injured Jehovah's Witnesses: a sixteen-year experience of treatment and transfusion dilemmas at a level I trauma center. J Trauma. 1995;39:681-685.
    • (1995) J. Trauma. , vol.39 , pp. 681-685
    • Nelson, B.S.1    Heiskell, L.E.2    Cemaj, S.3    O'Callaghan, T.A.4    Koller, C.E.5
  • 6
    • 0036345744 scopus 로고    scopus 로고
    • Severe anemia after gastrointestinal hemorrhage in a Jehovah's Witness: New treatment strategies
    • Gannon CJ, Napolitano LM. Severe anemia after gastrointestinal hemorrhage in a Jehovah's Witness: new treatment strategies. Crit Care Med. 2002;30:1893-1895.
    • (2002) Crit. Care Med. , vol.30 , pp. 1893-1895
    • Gannon, C.J.1    Napolitano, L.M.2
  • 7
    • 0037018495 scopus 로고    scopus 로고
    • Blood substitute and erythropoietin therapy in a severely injured Jehovah's witness
    • Cothren C, Moore EE, Offner PJ, Haenel JB, Johnson JL. Blood substitute and erythropoietin therapy in a severely injured Jehovah's witness. N Engl J Med. 2002;346:1097-1098.
    • (2002) N. Engl. J. Med. , vol.346 , pp. 1097-1098
    • Cothren, C.1    Moore, E.E.2    Offner, P.J.3    Haenel, J.B.4    Johnson, J.L.5
  • 8
    • 4344603653 scopus 로고    scopus 로고
    • How low is too low? Cardiac risks with anemia
    • Fakhry SM, Fata P. How low is too low? Cardiac risks with anemia. Crit Care. 2004;8(Suppl 2):S11-S14.
    • (2004) Crit. Care , vol.8 , Issue.2 SUPPL.
    • Fakhry, S.M.1    Fata, P.2
  • 9
    • 0141719806 scopus 로고    scopus 로고
    • Red cell transfusion "trigger": A review
    • Petrides M. Red cell transfusion "trigger": a review. South Med J. 2003;96:664-667.
    • (2003) South Med. J. , vol.96 , pp. 664-667
    • Petrides, M.1
  • 10
    • 0035098668 scopus 로고    scopus 로고
    • Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group
    • DeFoe GR, Ross CS, Olmstead EM, et al. Lowest hematocrit on bypass and adverse outcomes associated with coronary artery bypass grafting. Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg. 2001;71:769-776.
    • (2001) Ann. Thorac. Surg. , vol.71 , pp. 769-776
    • DeFoe, G.R.1    Ross, C.S.2    Olmstead, E.M.3
  • 12
    • 0343360868 scopus 로고    scopus 로고
    • A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group
    • Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409-417.
    • (1999) N. Engl. J. Med. , vol.340 , pp. 409-417
    • Hebert, P.C.1    Wells, G.2    Blajchman, M.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.